Zobrazeno 1 - 10
of 22
pro vyhledávání: '"P E Valk"'
Autor:
Kiruphagaran Thangaraju, Upendra Katneni, Imo J. Akpan, Kenichi Tanaka, Tiffany Thomas, Saini Setua, Julie A. Reisz, Francesca Cendali, Fabia Gamboni, Travis Nemkov, Stacie Kahn, Alexander Z. Wei, Jacob E. Valk, Krystalyn E. Hudson, David J. Roh, Chiara Moriconi, James C. Zimring, Angelo D'Alessandro, Steven L. Spitalnik, Richard O. Francis, Paul W. Buehler
Publikováno v:
Frontiers in Medicine, Vol 8 (2022)
Aging and obesity independently contribute toward an endothelial dysfunction that results in an imbalanced VWF to ADAMTS13 ratio. In addition, plasma thrombin and plasmin generation are elevated and reduced, respectively, with increasing age and also
Externí odkaz:
https://doaj.org/article/b551da122a624fafad94df464e4f7a0a
Autor:
Angelo D’Alessandro, Tiffany Thomas, Imo J. Akpan, Julie A. Reisz, Francesca I. Cendali, Fabia Gamboni, Travis Nemkov, Kiruphagaran Thangaraju, Upendra Katneni, Kenichi Tanaka, Stacie Kahn, Alexander Z. Wei, Jacob E. Valk, Krystalyn E. Hudson, David Roh, Chiara Moriconi, James C. Zimring, Eldad A. Hod, Steven L. Spitalnik, Paul W. Buehler, Richard O. Francis
Publikováno v:
Cells, Vol 10, Iss 9, p 2293 (2021)
The Corona Virus Disease 2019 (COVID-19) pandemic represents an ongoing worldwide challenge. The present large study sought to understand independent and overlapping metabolic features of samples from acutely ill patients (n = 831) that tested positi
Externí odkaz:
https://doaj.org/article/27de5964efc4401ba663eeea747c8d81
Autor:
C S, Yap, M A, Seltzer, C, Schiepers, S S, Gambhir, J, Rao, M E, Phelps, P E, Valk, J, Czernin
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 42(9)
FDG PET has emerged as an important clinical imaging modality for diagnosing and staging cancer. However, the impact of FDG PET on staging and managing patients with breast cancer from the referring physician's point of view is unknown.The referring
Autor:
P E, Valk
Publikováno v:
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR). 44(2)
This article discusses models of efficacy, design of clinical trials and the role of mathematical modeling in diagnostic technology evaluation and determination of cost-effectiveness. A multi-tiered model of efficacy, which views diagnostic imaging a
Autor:
P E, Valk
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 41(7)
Autor:
E. Abella-Columna, P. E. Valk
Publikováno v:
Atlas of Clinical PET in Oncology ISBN: 9783642640933
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::069cc0cb1455c2473f1753136a08c391
https://doi.org/10.1007/978-3-642-59706-0_6
https://doi.org/10.1007/978-3-642-59706-0_6
Autor:
P. E. Valk
Publikováno v:
PET in Oncology ISBN: 9783642642203
The cost effectiveness of a diagnostic or therapeutic procedure is most commonly expressed in terms of cost effectiveness ratio: Cost Effectiveness Ratio = Net Cost Increase/Net Effectiveness Increase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87b5446149d8323c63a90b021e008ac4
https://doi.org/10.1007/978-3-642-60010-4_8
https://doi.org/10.1007/978-3-642-60010-4_8
Autor:
B D Shah, Sanjiv S. Gambhir, Eric M. Hart, P E Valk, Carl K. Hoh, J E Shepherd, Michael E. Phelps, T Emi
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 16(6)
PURPOSE AND METHODS Multiple strategies are currently being used to manage patients who present with indeterminate solitary pulmonary nodules (SPN). We have used decision-analysis models to assess the cost-effectiveness of various strategies for the
Autor:
P. E. Valk
Publikováno v:
PET in der Onkologie ISBN: 9783662092439
Die Kosteneffektivitat einer diagnostischen oder therapeutischen Prozedur ist am haufigsten beschrieben worden als die Kosteneffektivitatsratio, die sich ergibt aus der Nettozuwachsrate an Kosten dividiert durch die Nettozuwachsrate an Effektivitat d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4ac99047131cc488d94d8fe4b8dfd84
https://doi.org/10.1007/978-3-662-09242-2_7
https://doi.org/10.1007/978-3-662-09242-2_7
Publikováno v:
AJNR Am J Neuroradiol
PURPOSE: To search for metabolic correlates of clinical and electrophysiological abnormalities in violent subjects. METHODS: Seven subjects with histories of extremely violent behavior were studied with positron emission tomography (PET) with fludeox